Roche buys Telavant and its IBD drug for $7.1 billion - C&EN - American Chemical Society

Retrieved on: 2023-10-30 00:27:58

Tags for this article:

Click the tags to see associated articles and topics

Roche buys Telavant and its IBD drug for $7.1 billion - C&EN - American Chemical Society. View article details on hiswai:

Excerpt

The French pharma giant Roche will buy Telavant Holdings from Roivant Sciences and Pfizer for $7.1 billion. The target of the acquisition is ...

Article found on: cen.acs.org